Immediate Impact
3 by Nobel laureates 54 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Cemil Bilir being referenced
MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation
2019
Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Cemil Bilir | 131 | 85 | 168 | 48 | 536 | |
| Hui Wu | 83 | 100 | 277 | 39 | 639 | |
| Liza U. Ljungberg | 88 | 43 | 164 | 29 | 562 | |
| Wenjie Lu | 98 | 44 | 236 | 38 | 647 | |
| Xiuzhen Li | 82 | 63 | 212 | 32 | 487 | |
| Wei Chen | 54 | 69 | 261 | 35 | 592 | |
| Mengqi Gao | 137 | 77 | 180 | 25 | 626 | |
| Barbara Kutryb-Zając | 132 | 38 | 265 | 48 | 642 | |
| Ziyu Meng | 80 | 40 | 264 | 31 | 620 | |
| Wenqi Li | 70 | 54 | 270 | 52 | 638 | |
| Yi Xu | 61 | 36 | 247 | 31 | 596 |
All Works
Login with ORCID to disown or claim papers
Loading papers...